Patent details

Basic Information

Publication number:

EP1690536

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP060112075

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders

French Title of Invention:

Utilisation de l' hydrogène fumarate de l'ester de l'acide r-(+)-2-(3-diisopropylamino-1-phenylpropyl)- 4-hydroxy-methyl-phenylisobutyrique pour le traitement de l'incontinence urinaire et d'autres maladies spasmogeniques

German Title of Invention:

Verwendung von r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-Phenylisobuttersäureester Hydrogenfumarat zur Behandlung von Harndrang-Inkontinenz und anderen spasmogenen Leiden

SPC Number:

Dates

Filing date:

15/11/2000

Grant date:

14/05/2008

EP Publication Date:

14/05/2008

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/08/2006

EP B1 Publication Date:

14/05/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

15/11/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/08/2017

 

 

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

History of Owners

From:

15/11/2000

To:

30/08/2017

Name:

SCHWARZ PHARMA AG

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

Name:

Meese Claus

Address:

Germany (DE)

Licencee

Name:

Pfizer Inc.

From:

30/08/2017

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

To:

Priority

Priority Number:

19955190

Priority Date:

16/11/1999

Priority Country:

Germany (DE)

Classification

Main IPC Class:

A61K 31/222;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/05

Publication date:

13/09/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

MED

Bulletin edition number:

2017/06

Publication date:

10/10/2017

Description:

Section K : Modifications and recordals into the register

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000323A

Date Registered:

30/08/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20170000324C

Date Registered:

30/08/2017

Licence Effective Date:

05/01/2017

Licence Expiration Date:

Scope of Licence:

Exclusive

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

11/11/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
31/08/2017	Outgoing Correspondence	1
30/08/2017	Request For Change	4
07/09/2017	Outgoing Correspondence	1
30/08/2017	Request For Change	1